Fas‐mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous FasL‐expressing T cells
Open Access
- 1 October 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 107 (1) , 99-105
Abstract
Given the known role of the fas cytolytic pathway in B‐cell regulation, we evaluated whether fas–fasL interactions might induce chronic lymphocytic leukaemia (CLL) cell death. De novo CLL cells expressed a low level of surface fas, and were not lysed by fasL‐bearing cells. CLL cells cultured in media containing the type I cytokines interleukin (IL)‐12 or interferon (IFN)‐α had increased fas expression, and were readily lysed by fasL‐bearing cells. In contrast, the type II cytokine IL‐4 did not increase CLL cell fas, and abrogated type I cytokine‐induced fas up‐regulation. With prolonged culture, IL‐4 exposed CLL cells expressed an intermediate level of fas; however, such CLL cells were resistant to fas‐mediated lysis. These results indicate that IL‐4 inhibits fas‐mediated killing of CLL cells at the level of both fas receptor expression and post‐receptor events. Additionally, we have defined in vitro culture conditions which generate fasL‐bearing T cells from CLL patients; such T cells efficiently mediated fas‐based lysis of autologous fas‐positive CLL cells. We therefore conclude that type I and type II cytokines differentially regulate the fas pathway in CLL cells, and that a combination of type I cytokines and fasL‐expressing T cells may represent a new approach to the immunotherapy of CLL.Keywords
This publication has 26 references indexed in Scilit:
- IL4 production and increased CD30 expression by a unique CD8+ T‐cell subset in B‐cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 1999
- Role of the CD40 and CD95 (APO‐1/Fas) antigens in the apoptosis of human B‐cell malignanciesBritish Journal of Haematology, 1997
- Fas (CD95)/Fas ligand interactions regulate antigen‐specific, major histocompatibility complex‐restricted T/B cell proliferative responsesEuropean Journal of Immunology, 1996
- Apoptotic cell death induced by a mouse‐human anti‐APO‐1 chimeric antibody leads to tumor regressionInternational Journal of Cancer, 1994
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Alpha‐interferon (α‐IFN) protects B‐chronic lymphocytic leukaemia cells from apoptotic cell death in vitroBritish Journal of Haematology, 1994
- Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.Journal of Experimental Medicine, 1993
- Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.Journal of Experimental Medicine, 1993
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.Journal of Experimental Medicine, 1992
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992